(Q33900408)

29 July 2017

1 reference

title

Intravenous to oral (iv:po) anti-infective conversion therapy (English)

1 reference

29 July 2017

Wetzstein GA

1

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

7

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

170-176

1 reference

Sequential antimicrobial therapy--the role of quinolones

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Home treatment of febrile neutropenia: an empirical oral antibiotic regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Intravenous-to-oral antibiotic switch therapy. A cost-effective approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Streamlining antimicrobial therapy for lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Infectious complications of indwelling vascular catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Sequential switch therapy for lower respiratory tract infections: a European perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Third generation cephalosporins in the parenteral to oral switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

Cost-effectiveness and value of an IV switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700211

10.1177/107327480000700211

21 January 2018

Identifiers

DOI

0 references

1 reference